Highline Wealth Partners’s Moderna MRNA Stock Holding History

Highline Wealth Partners’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$630	Buy	+9	New	+$466	﹤0.01%	1322
2025 Q1	–	Sell	-54	Closed	-$2.25K	–	1040
2024 Q4	$2.25K	Hold	54	–	–	﹤0.01%	443
2024 Q3	$3.61K	Sell	54 -2	-4%	-$184	﹤0.01%	387
2024 Q2	$6.65K	Buy	56 +2	+4%	+$253	﹤0.01%	259
2024 Q1	$5.75K	Hold	54	–	–	﹤0.01%	260
2023 Q4	$5.37K	Hold	54	–	–	﹤0.01%	244
2023 Q3	$5.58K	Buy	+54	New	+$6.02K	﹤0.01%	221

Other funds holding MRNA

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

MIM

Morningstar Investment Management Chicago, Illinois $1.62B AUM 13.96% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $285M AUM 18.63% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Highline Wealth Partners's MRNA Position: Q2 2026 in Review

Highline Wealth Partners opened a new position in Moderna (MRNA) in Q2 2026: 9 shares worth $630. The stake represents ﹤0.01% of the portfolio and ranks #1322 among its holdings. This is a return to the name: Highline Wealth Partners previously reported a position in MRNA as recently as Q4 2024.

Highline Wealth Partners first reported a position in MRNA in Q3 2023 and has held it in 7 quarters since. The position peaked at $6.65K in Q2 2024. 131 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Highline Wealth Partners held 9 shares of Moderna worth $630 as of Q2 2026.
Moderna was a new Highline Wealth Partners position in Q2 2026.
Moderna made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #1322 holding.
Highline Wealth Partners first reported a position in Moderna in Q3 2023 and has held it in 7 quarters since.
Highline Wealth Partners's Moderna position peaked at $6.65K in Q2 2024.
131 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.